Pt-141 (bremelanotide recalls

The FDA has published 1 recall involving Pt-141 (bremelanotide since 2022. The latest was reported on 27 Apr 2022. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2022

Last 12 months0reported

Class I00% of total

Ongoing0latest 27 Apr 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why pt-141 (bremelanotide is recalled

Sterility1100%

Companies

North American Custom Laboratories1100%

By year

20221100%

All pt-141 (bremelanotide recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
27 Apr 2022Drug	CLASS II	PT-141 (Bremelanotide Acetate) 10 mg/mL Injection vials recalled	North American Custom Laboratories	Sterility	Nationwide

Should you stop taking Pt-141 (bremelanotide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.